We helped Coupa and its Board navigate their founder to Chief Executive Officer transition, placing Rob Bernshteyn as CEO. Rob led Coupa from $1M ARR through one of the most successful IPOs in 2016.
We initially partnered with Spark Therapeutics in 2013, shortly after their founding. Spark went on to receive FDA approval for Retinal Dystrophy gene therapy, went public in 2015 and today has a market cap of ~$1.9B.
Since 2012, we've helped founder & CEO Julie Wainright build TheRealReal into the luxury consigment leader, completing six CXO-level searches as the company scales to IPO.
We first partnered with Facebook in 2006, when only .edu addresses were accepted and when the site had 7M monthly users.
Anaplan had 30 employees and <$1M in revenue when we placed Fred Laluyaux as CEO. We continued to help build Anaplan's executive team as the company grew into a public company and the undisputed leader in real-time financial planning and decision-making.